Iparomlimab and Tuvonralimab Plus Chemotherapy as Neoadjuvant Therapy for Ovarian Cancer（Phase II）
NCT07673835
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
PROCEDURE:
Neoadjuvant Therapy Plus Surgery
Sponsor
Obstetrics & Gynecology Hospital of Fudan University